Development of a Humanized Antibody with High Therapeutic Potential against Dengue Virus Type 2

• Pi-Chun Li,

  Affiliations Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan, Institute of Cellular and Organismic Biology, Academia Sinica, Taipei, Taiwan

  ⨯
• Mei-Ying Liao,

  Affiliation Institute of Cellular and Organismic Biology, Academia Sinica, Taipei, Taiwan

  ⨯
• Ping-Chang Cheng,

  Affiliation Institute of Cellular and Organismic Biology, Academia Sinica, Taipei, Taiwan

  ⨯
• Jian-Jong Liang,

  Affiliation Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan

  ⨯
• I-Ju Liu,

  Affiliation Institute of Cellular and Organismic Biology, Academia Sinica, Taipei, Taiwan

  ⨯
• Chien-Yu Chiu,

  Affiliation Institute of Cellular and Organismic Biology, Academia Sinica, Taipei, Taiwan

  ⨯
• Yi-Ling Lin,

  Affiliation Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan

  ⨯
• Gwong-Jen J. Chang,

  Affiliation Arbovirus Diseases Branch, Division of Vector-Borne Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, United States Department of Health and Human Services, Fort Collins, Colorado, United States of America

  ⨯
• Han-Chung Wu

  * E-mail: hcw0928@gate.sinica.edu.tw

  Affiliations Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan, Institute of Cellular and Organismic Biology, Academia Sinica, Taipei, Taiwan

  ⨯